Oxycinchophen

This classification denotes a uricosuric agent and nonnarcotic analgesic with the molecular formula C16H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) UK6392GD5W, chemically known as 4-quinolinecarboxylic acid, 3-hydroxy-2-phenyl- (9ci) but more generally known as oxycinchophen, which bears US NIH Compound Identifier 10239. European Medicines Agency schedules Oxycinchophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09559MIG. The term OXYCINCHOPHEN is an International Non-Proprietary Name. World Health Organization schedules oxycinchophen in its Anatomical Therapeutic Chemical (ATC) Classification. OXYCINCHOPHEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule oxycinchophen under HS 29334910 and SITC 51575. As of Q4 2014, OXYCINCHOPHEN remains US FDA's Preferred Term for this commodity. Oxycinchophen bears US NLM identifiers UMLS ID C1882245 and NCI Concept Code C66278. SMILES: OC1C(C2C(NC1C1CCCCC1)CCCC2)C(=O)O.